Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Fisetin to Improve PRP and Losartan Benefit in FAI and Labral Tear
NCT05025956Phase 2Active, not recruiting
- Sponsor
- Steadman Philippon Research Institute
- Start
- Oct 2021
- Primary completion
- Oct 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of fisetin in Femoroacetabular impingement (FAI), acetabular labrum tear, sponsored by Steadman Philippon Research Institute. Started Oct 2021; status: active, not recruiting.
02
Drugs
fisetin
03
Conditions
Femoroacetabular impingement (FAI)acetabular labrum tear
Beyond the preview
Go deeper on NCT05025956.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05025956.